Probing neutralizing-antibody responses against emerging measles viruses (MVs): Immune selection of MV by H protein-specific antibodies?

Journal of General Virology

Volumn 86, Issue 2, 2005, Pages 365-374

  Santibanez, Sabine ^a   Niewiesk, Stefan ^b,d   Heider, Alla ^a   Schneider Schaulies, Jürgen ^b   Berbers, Guy A M ^c   Zimmermann, Albert ^a,e   Halenius, Anne ^a   Wolbert, Anne ^a   Deitemeier, Ingrid ^a   Tischer, Annedore ^a   Hengel, Hartmut ^a,e  

^a ROBERT KOCH INSTITUTE   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d OHIO STATE UNIVERSITY   (United States)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIBODY; EPITOPE; HEMAGGLUTININ; HYBRID PROTEIN; MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; ENDEMIC DISEASE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENOTYPE; GERMAN FEDERAL REPUBLIC; GLYCOSYLATION; HUMAN; IMMUNOPRECIPITATION; MEASLES; MEASLES VIRUS; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; VACCINATION; VIRUS GENE; VIRUS IMMUNITY; VIRUS ISOLATION; VIRUS STRAIN;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CONVALESCENCE; GENOTYPE; GERMANY; HUMANS; IMMUNE SERA; INFANT; MEASLES; MEASLES VACCINE; MEASLES VIRUS; MIDDLE AGED; NEUTRALIZATION TESTS; RATS; VACCINATION; VIRAL FUSION PROTEINS; VIRAL PROTEINS;

GOSSYPIUM HIRSUTUM; MEASLES VIRUS; SIGMODON;

EID: 13644260929     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80467-0     Document Type: Article

References (60)

1. Bouche, F. B., Ertl, O. T. & Muller, C. P. (2002). Neutralizing B cell response in measles. Viral Immunol 15, 451-471.
2. Cattaneo, R. & Rose, J. K. (1993). Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J Virol 67, 1493-1502.
3. Damien, B., Huiss, S., Schneider, F. & Muller, C. P. (1998). Susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons. J Med Virol 56, 85-90.
4. Dörig, R. E., Marcil, A., Chopra, A. & Richardson, C. D. (1993). The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295-305.
5. Duarte, E. A., Novella, I. S., Weaver, S. C. & 7 other authors (1994). RNA virus quasispecies: significance for viral disease and epidemiology. Infect Agents Dis 3, 201-214.
6. Edmonson, M. B., Addiss, D. G., McPherson, J. T., Berg, J. L., Circo, S. R. & Davis, J. P. (1990). Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 263, 2467-2471.
7. Erlenhöfer, C., Wurzer, W. J., Löffler, S., Schneider-Schaulies, S., ter Meulen, V. & Schneider-Schaulies, J. (2001). CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J Virol 75, 4499-4505.
8. Erlenhöfer, C., Duprex, W. P., Rima, B. K., ter Meulen, V. & Schneider-Schaulies, J. (2002). Analysis of receptor (CD46, CD150) usage by measles virus. J Gen Virol 83, 1431-1436.
9. Ertl, O. T., Wenz, D. C., Bouche, F. B., Berbers, G. A. M. & Muller, C. P. (2003). Immunodominant domains of the Measles virus hemagglutinin protein eliciting a neutralizing human B cell response. Arch Virol 148, 2195-2206.
10. Fayolle, J., Verrier, B., Buckland, R. & Wild, T. F. (1999). Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization. J Virol 73, 787-790.
11. Fournier, P., Ammerlaan, W., Ziegler, D. & 7 other authors (1996). Differential activation of T cells by antibody-modulated processing of the flanking sequences of class II-restricted peptides. Int Immunol 8, 1441-1451.
12. Fournier, P., Brons, N. H. C., Berbers, G. A. M., Wiesmüller, K. H., Fleckenstein, B. T., Schneider, F., Jung, G. & Muller, C. P. (1997). Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis. J Gen Virol 78, 1295-1302.
13. Giraudon, P. & Wild, T. F. (1981). Monoclonal antibodies against measles virus. J Gen Virol 54, 325-332.
14. Giraudon, P. & Wild, T. F. (1985). Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 144, 46-58.
15. Hay, A. J., Gregory, V., Douglas, A. R. & Lin, Y. P. (2001). The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 356, 1861-1870.
16. Hengel, H., Eßlinger, C., Pool, J., Goulmy, E. & Koszinowski, U. H. (1995). Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol 76, 2987-2997.
17. Hengel, H., Koopmann, J. O., Flohr, T., Muranyi, W., Goulmy, E., Hammerling, G. J., Koszinowski, U. H. & Momburg, F. (1997). A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6, 623-632.
18. Holland, J. J., de la Torre, J. C., Steinhauer, D. A., Clarke, D., Duarte, E. & Domingo, E. (1989). Virus mutation frequencies can be greatly underestimated by monoclonal antibody neutralization of virions. J Virol 63, 5030-5036.
19. Hu, A., Sheshberadaran, H., Norrby, E. & Kövamees, J. (1993). Molecular characterization of epitopes on the measles virus hemagglutinin protein. Virology 192, 351-354.
20. Hu, A., Cattaneo, R., Schwartz, S. & Norrby, E. (1994). Role of N-linked oligosaccharide chains in the processing and antigenicity of measles virus haemagglutinin protein. J Gen Virol 75, 1043-1052.
21. Jin, L., Richards, A. & Brown, D. W. G. (1996). Development of a dual target-PCR for detection and characterization of measles virus in clinical specimens. Mol Cell Probes 10, 191-200.
22. Johnston, I. C. D., ter Meulen, V., Schneider-Schaulies, J. & Schneider-Schaulies, S. (1999). A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism. J Virol 73, 6903-6915.
23. Klagge, I. M., ter Meulen, V. & Schneider-Schaulles, S. (2000). Measles virus-induced promotion of dendritic cell maturation by soluble mediators does not overcome the immunosuppressive activity of viral glycoproteins on the cell surface. Eur J Immunol 30, 2741-2750.
24. Klingele, M., Hartter, H. K., Adu, F., Ammerlaan, W., Ikusika, W. & Muller, C. P. (2000). Resistance of recent measles virus wild-type isolates to antibody-mediated neutralization by vaccinees with antibody. J Med Virol 62, 91-98.
25. Kubo, H., Iritani, N. & Seto, Y. (2003). Co-circulation of two genotypes of measles virus and mutual change of the prevailing genotypes every few years in Osaka, Japan. J Med Virol 69, 273-278.
26. Langedijk, J. P. M., Daus, F. J. & van Oirschot, J. T. (1997). Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin. J Virol 71, 6155-6167.
27. Liebert, U. G., Flanagan, S. G., Löffler, S., Baczko, K., ter Meulen, V. & Rima, B. K. (1994). Antigenic determinants of measles virus hemagglutinin associated with neurovirulence. J Virol 68, 1486-1493.
28. Moeller, K., Duffy, I., Duprex, P. & 7 other authors (2001). Recombinant measles viruses expressing altered hemagglutinin (H) genes: functional separation of mutations determining H antibody escape from neurovirulence. J Virol 75, 7612-7620.
29. Muller, C. P. (2001). Measles elimination: old and new challenges? Vaccine 19, 2258-2261.
30. Muller, C. P., Huiss, S. & Schneider, F. (1996). Secondary immune responses in parents of children with recent measles. Lancet 348, 1379-1380.
31. Naniche, D., Varior-Krishnan, F., Cervoni, F., Wild, T. F., Rossi, B., Rabourdin-Combe, C. & Gerlier, D. (1993). Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67, 6025-6032.
32. Niewiesk, S. (1999). Cotton rats (Sigmodon hispidus) an animal model to study the pathogenesis of measles virus infection. Immunol Lett 65, 47-50.
33. Niewiesk, S., Eisenhuth, I., Fooks, A., Clegg, J. C. S., Schnorr, J.-J., Schneider-Schaulies, S. & ter Meulen, V. (1997). Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins. J Virol 71 7214-7219.
34. Niewiesk, S., Götzelmann, M. & ter Meulen, V. (2000). Selective in vivo suppression of T lymphocyte responses in experimental measles virus infection. Proc Natl Acad Sci U S A 97, 4251-4255.
35. Ohgimoto, S., Ohgimoto, K., Niewiesk, S. & 7 other authors (2001). The haemagglutinin protein is an important determinant of measles virus tropism for dendritic cells in vitro. J Gen Virol 82, 1835-1844.
36. Parks, C. L., Lerch, R. A., Walpita, P., Wang, H.-P., Sidhu, M. S. & Udem, S. A. (2001). Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage. J Virol 75, 910-920.
37. Pederson, I. R., Mordhorst, C. H., Glikmann, G. & von Magnus, H. (1989). Subclinical measles infection in vaccinated seropositive individuals in arctic Greenland. Vaccine 7, 345-348.
38. Pfeuffer, J., Püschel, K., ter Meulen, V., Schneider-Schaulies, J. & Niewiesk, S. (2003). Extent of measles virus spread and immune suppression differentiates between wild-type and vaccine strains in the cotton rat model (Sigmodon hispidus). J Virol 77, 150-158.
39. Pütz, M. M., Hoebeke, J., Ammerlaan, W., Schneider, S. & Muller, C. P. (2003). Functional fine-mapping and molecular modeling of a conserved loop epitope of the measles virus hemagglutinin protein. Eur J Biochem 270, 1515-1527.
40. Rota, J. S., Hummel, K. B., Rota, P. A. & Bellini, W. J. (1992). Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 188, 135-142.
41. Rota, J. S., Wang, Z.-D., Rota, P. A. & Bellini, W. J. (1994). Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res 31, 317-330.
42. Saito, H., Nakagomi, O. & Morita, M. (1995). Molecular identification of two distinct hemagglutinin types of measles virus by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Mol Cell Probes 9, 1-8.
43. Santibanez, S., Heider, A., Gerike, E., Agafonov, A. & Schreier, E. (1999). Genotyping of measles virus isolates from Central Europe and Russia. J Med Virol 58, 313-320.
44. Santibanez, S., Tischer, A., Heider, A., Siedler, A. & Hengel, H. (2002). Rapid replacement of endemic measles virus genotypes. J Gen Virol 83, 2699-2708.
45. Schneider-Schaulies, J., ter Meulen, V. & Schneider-Schaulies, S. (2001). Measles virus interactions with cellular receptors: consequences for viral pathogenesis. J Neurovirol 7, 391-399.
46. Schrag, S. J., Rota, P. A. & Bellini, W. J. (1999). Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance. J Virol 73 51-54.
47. Schulze, I. T. (1997). Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. J Infect Dis 176 (Suppl. 1), S24-S28.
48. Sinitsyna, O. A., Khudaverdyan, O. E., Steinberg, L. L., Nagieva, F. G., Lotte, V. D., Dorofeeva, L. V., Rozina, E. E. & Boriskin, Yu. S. (1990). Further-attenuated measles vaccine: virus passages affect viral surface protein expression, immunogenicity and histopathology pattern in vivo. Res Virol 141, 517-531.
49. Skehel, J. J., Stevens, D. J., Daniels, R. S., Douglas, A. R., Knossow, M., Wilson, I. A. & Wiley, D. C. (1984). A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A 81, 1779-1783.
50. Stern, L. B.-L., Greenberg, M., Gershoni, J. M. & Rozenblatt, S. (1995). The hemagglutinin envelope protein of canine distemper virus (CDV) confers cell tropism as illustrated by CDV and measles virus complementation analysis. J Virol 69, 1661-1668.
51. Tatsuo, H., Ono, N., Tanaka, K. & Yanagi, Y. (2000). SLAM (CDw150) is a cellular receptor for measles virus. Nature 406, 893-897.
52. Tischer, A., Santibanez, S., Siedler, A., Heider, A. & Hengel, H. (2004). Laboratory investigations are indispensable to monitor the progress of measles elimination - results of the German Measles Sentinel 1999-2003. J Clin Virol 31, 165-178.
53. van Binnendijk, R. S., van den Hof, S., van den Kerkhof, H., Kohl, R. H. G., Woonink, F., Berbers, G. A. M., Conyn-van Spaendonck, M. A. E. & Kimman, T. G. (2003). Evaluation of serological and virological tests in the diagnosis of clinical and subclinical measles virus infections during an outbreak of measles in the Netherlands. J Infect Dis 188, 898-903.
54. Vardas, E. & Kreis, S. (1999). Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual. J Clin Virol 13, 173-179.
55. Varsanyi, T. M., Morein, B., Löve, A. & Norrby, E. (1987). Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein. J Virol 61, 3896-3901.
56. Vongpunsawad, S., Oezgun, N., Braun, W. & Cattaneo, R. (2004). Selectively receptor-blind measles viruses: identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol 78 302-313.
57. WHO (2003). Update of the nomenclature for describing the genetic characteristics of wild-type measles viruses: new genotypes and reference strains. Wkly Epidemiol Rec 78, 229-232.
58. Wild, T. F. & Buckland, R. (1995). Functional aspects of envelope-associated measles virus proteins. Curr Top Microbiol Immunol 191, 51-64.
59. Wild, T. F., Malvoisin, E. & Buckland, R. (1991). Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. J Gen Virol 72, 439-442.
60. Ziegler, D., Fournier, P., Berbers, G. A. H. & 7 other authors (1996). Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies. J Gen Virol 77, 2479-2489.